<DOC>
	<DOCNO>NCT00239863</DOCNO>
	<brief_summary>This study evaluate safety efficacy FTY720 versus mycophenolate mofetil ( MMF , Roche brand ) combine cyclosporine corticosteroid patient receive kidney transplant .</brief_summary>
	<brief_title>Efficacy Safety FTY720 Versus Mycophenolate Mofetil ( MMF , Roche Brand ) de Novo Adult Renal Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Fingolimod Hydrochloride</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Inclusion Criteria Completion core study Exclusion Criteria Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Transplantation , kidney , organ transplant</keyword>
</DOC>